PDF file: 441-2916_immunological_mechanism_of_action_and_biodistribution.pdf
OPQ ID: 441-2916
Session: 441
Question number: Q-2916
Sessional paper: Q-2916
Title: immunological mechanism of action and biodistribution
Short description: 
Topic: vaccines
Identified concern: 
Keywords: 
Agencies: HC
Date asked: 2024-06-18
Date tabled: 
Submitted by: Mr. Allison (Niagara West)
Reply by: Minister of Health
Responded by: Mr. Yasir Naqvi
Pages: 2
Status: not processed
Alert: yellow
Questions asked: 7
Questions answered: 1
Percent responded: 14%
Referenced sources: Canada.ca, COVID-19 vaccines and treatments portal
Referenced links: (none extracted)
Official link: https://www.google.com/search?q=Q-2916+ourcommons.ca
PDF URL: https://ivim.ca/foi/opq/r/441-2916_immunological_mechanism_of_action_and_biodistribution.pdf
TXT URL: https://ivim.ca/foi/opq/r/441-2916.txt
Original filename: Q-2916_HC immunological mechanism of action and biodistribution.pdf
Local source path: C:\Users\Dmitry\Documents\CODES\OPQ-App\data-raw\OPQ\ALL OPQ TO DATE\2022\Q-2916_HC immunological mechanism of action and biodistribution.pdf
Machine extracted at: 2026-06-30 12:58:27

References / links:
- Canada.ca
- COVID-19 vaccines and treatments portal

Machine notes:
(none)

Question text preview:
With regard to Health Canada's (HC) decision to approve the COVID-19 modRNA vaccines and the Prime Minister's subsequent support for the vaccine mandates in the federal public sector and vaccine passports for travel purposes during the COVID-19 pandemic: (a) what is the immunological mechanism of action of the COVID-19 mRNA vaccines that enables them to stop the spread of SARS-CoV2;
(b) what data supports this mechanism of action;
(c) who or what agency provided the data and verified the data;
(d) when was this data provided to (i)
HC, (ii) the Office of the Prime Minister;
(e) what data did Pfizer and Moderna produce to HC that demonstrated (i) the period of time the spike protein is produced in the body, (ii) where in the body the spike protein is produced; and (f) in relation to (e), what was the period of time Pfizer and Moderna tracked the spike protein in their clinical studies?